BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27005321)

  • 21. The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation.
    Roberts V; Stagg J; Dwyer KM
    Front Immunol; 2014; 5():64. PubMed ID: 24600452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.
    Antonioli L; Blandizzi C; Pacher P; Haskó G
    Pharmacol Rev; 2019 Jul; 71(3):345-382. PubMed ID: 31235653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological roles of purinergic signaling in the liver.
    Vaughn BP; Robson SC; Burnstock G
    J Hepatol; 2012 Oct; 57(4):916-20. PubMed ID: 22709619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purines, purinergic receptors, and cancer.
    Di Virgilio F
    Cancer Res; 2012 Nov; 72(21):5441-7. PubMed ID: 23090120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purinergic signaling in the organ of Corti: Potential therapeutic targets of sensorineural hearing losses.
    Berekméri E; Szepesy J; Köles L; Zelles T
    Brain Res Bull; 2019 Sep; 151():109-118. PubMed ID: 30721767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
    Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
    Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.
    Sun X; Han L; Seth P; Bian S; Li L; Csizmadia E; Junger WG; Schmelzle M; Usheva A; Tapper EB; Baffy G; Sukhatme VP; Wu Y; Robson SC
    Hepatology; 2013 Jan; 57(1):205-16. PubMed ID: 22859060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues.
    Rhett JM; Fann SA; Yost MJ
    Tissue Eng Part B Rev; 2014 Oct; 20(5):392-402. PubMed ID: 24279914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases.
    Andrejew R; Glaser T; Oliveira-Giacomelli Á; Ribeiro D; Godoy M; Granato A; Ulrich H
    Adv Exp Med Biol; 2019; 1201():275-353. PubMed ID: 31898792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation.
    Chernogorova P; Zeiser R
    J Biomed Biotechnol; 2012; 2012():208204. PubMed ID: 23125523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
    Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
    J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From purines to purinergic signalling: molecular functions and human diseases.
    Huang Z; Xie N; Illes P; Di Virgilio F; Ulrich H; Semyanov A; Verkhratsky A; Sperlagh B; Yu SG; Huang C; Tang Y
    Signal Transduct Target Ther; 2021 Apr; 6(1):162. PubMed ID: 33907179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microglia and the Purinergic Signaling System.
    Calovi S; Mut-Arbona P; Sperlágh B
    Neuroscience; 2019 May; 405():137-147. PubMed ID: 30582977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of purinergic signaling during gastrointestinal inflammation.
    Roberts JA; Lukewich MK; Sharkey KA; Furness JB; Mawe GM; Lomax AE
    Curr Opin Pharmacol; 2012 Dec; 12(6):659-66. PubMed ID: 23063457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.
    Deaglio S; Robson SC
    Adv Pharmacol; 2011; 61():301-32. PubMed ID: 21586363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purinergic signaling involved in Müller cell function in the mammalian retina.
    Wurm A; Pannicke T; Iandiev I; Francke M; Hollborn M; Wiedemann P; Reichenbach A; Osborne NN; Bringmann A
    Prog Retin Eye Res; 2011 Sep; 30(5):324-42. PubMed ID: 21689780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purinergic signaling in Alzheimer's disease.
    Erb L; Woods LT; Khalafalla MG; Weisman GA
    Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutrophils: fast and furious-the nucleotide pathway.
    Rubenich DS; de Souza PO; Omizzollo N; Lenz GS; Sevigny J; Braganhol E
    Purinergic Signal; 2021 Sep; 17(3):371-383. PubMed ID: 33913070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of ectonucleotidases and their role in purinergic signaling.
    Zimmermann H
    Biochem Pharmacol; 2021 May; 187():114322. PubMed ID: 33161020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purinergic transmission in blood vessels.
    Ralevic V; Dunn WR
    Auton Neurosci; 2015 Sep; 191():48-66. PubMed ID: 26004513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.